1. "2021"
Formats
  1. Journal Article (2507)
  2. Meeting Abstract (1731)
  3. Review (604)
  4. Editorial (358)
  5. Book Section (123)
  6. Correspondence (107)
  7. Guidelines (103)
  8. Research Letter (91)
  9. Miscellaneous (52)
  10. Conference Paper (34)
  11. Book Whole (2)
Groups
  1. Department of Medicine (2534)
  2. Solid Tumor Oncology Division (1517)
  3. Sloan Kettering Institute Postdocs (1176)
  4. GSK Faculty (1088)
  5. Surgery (954)
  6. Survivorship Research (922)

More Groups

People
  1. Alexander Drilon (76)
  2. Miguel-Angel Perales (68)
  3. Sergio Giralt (66)
  4. Robert Motzer (65)
  5. Marc Ladanyi (62)
  6. Monica Morrow (57)

More People

Years
  1. 2021 (5712)
Publications
  1. Journal of Clinical Oncology (471)
  2. Blood (252)
  3. Annals of Oncology (148)
  4. Cancer Research (145)
  5. International Journal of Radiation Oncology, Biology, Physics (145)
  6. Journal of Thoracic Oncology (101)

More Publications

Publishers
  1. Elsevier Inc. (723)
  2. American Society of Clinical Oncology (522)
  3. Springer (381)
  4. Oxford University Press (360)
  5. Nature Publishing Group (344)
  6. American Association for Cancer Research (297)

More Publishers

Results (5712)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I first-in-class trial of MCARH109, a G protein coupled receptor class C group 5 member D (GPRC5D) targeted CAR T cell therapy in patients with relapsed or refractory multiple myeloma
    Meeting Abstract

    Mailankody, S.; Diamonte, C.; Fitzgerald, L.; Kane, P.; Wang, X.; Sikder, D. S.; Senechal, B.; Bermudez, V. P.; Frias, D.; Morgan, J.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • The genomic landscape of Waldenström Macroglobulinemia reveals sustained germinal center activity and late-developing copy number aberrations
    Meeting Abstract

    Maclachlan, K. H.; Bagratuni, T.; Kastritis, E.; Ziccheddu, B.; Lu, S. X.; Yellapantula, V. D.; Famulare, C.; Diamond, B.; Chojnacka, M.; Raj, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Real-world outcomes of axicabtagene ciloleucel (axi-cel) for the treatment of large B-cell lymphoma (LBCL): Impact of age and specific organ dysfunction
    Meeting Abstract

    Locke, F. L.; Jacobson, C.; Ma, L.; Dong, H.; Hu, Z. H.; Siddiqi, T.; Ahmed, S.; Ghobad, A.; Miklos, D. B.; Lin, Y.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Primary analysis of ZUMA-7: A phase 3 randomized trial of axicabtagene ciloleucel (axi-cel) versus standard-of-care therapy in patients with relapsed/refractory large B-cell lymphoma
    Meeting Abstract

    Locke, F. L.; Miklos, D. B.; Jacobson, C.; Perales, M. A.; Kersten, M. J.; Oluwole, O. O.; Ghobadi, A.; Rapoport, A. P.; McGuirk, J. P.; Pagel, J. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Targeting PRAME with TCR-mimic CAR T cells in AML
    Meeting Abstract

    Loeb, A. M.; Castro, S.; Nourigat-Mckay, C.; Perkins, L.; Pardo, L.; Leonti, A. R.; Tang, T. T.; Call, L. F.; Hylkema, T. A.; Scheinberg, D. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Subcutaneous epcoritamab in combination with R (2) (rituximab and lenalidomide) in patients with relapsed or refractory follicular lymphoma: Preliminary results from a phase 1/2 trial
    Meeting Abstract

    Linton, K. M.; Wahlin, B.; Leepa, S.; Morschhauser, F.; Elliot, B.; Liu, T.; Stirner, M. C.; Abbas, A.; Falchi, L.
    Blood (2021)

    Fulltext@MSK | Save
  • HMGA1 chromatin regulators drive progression in myeloproliferative neoplasms through epigenetic rewiring to induce networks involved in GATA2 and proliferation
    Meeting Abstract

    Li, L.; Kim, J. H.; Lu, W.; Cope, L.; Williams, D. M.; Kim, J.; Rampal, R.; Koche, R.; Xian, L.; Luo, L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • The BMP/SMAD pathway is a key mediator of leukemic transformation of TP53-mutant post-MPN AML
    Meeting Abstract

    Li, B.; An, W.; Wang, H.; Krishnan, A.; Mowla, S.; Baslan, T.; Koche, R.; Xiao, W.; Lowe, S.; Levine, R. L.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Real-world efficacy and safety outcomes for patients with relapsed or refractory (R/R) aggressive B-cell non-Hodgkin's lymphoma (aBNHL) treated with commercial tisagenlecleucel: Update from the Center for International Blood and Marrow Transplant Research (CIBMTR) registry
    Meeting Abstract

    Landsburg, D. J.; Frigault, M. J.; Hu, Z. H.; Jaglowski, S.; Locke, F. L.; Ho, C.; Perales, M. A.; Jacobson, C.; Hill, B. T.; Foley, S. R.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Rhesus macaques as a preclinical model organism for RUNX1-FPD
    Meeting Abstract

    Lee, B. C.; Zhou, Y.; Bresciani, E.; Ozkaya, N.; Shin, T.; Hong, S. G.; Liu, P. P.; Dunbar, C. E.
    Blood (2021)

    Fulltext@MSK | Save